International study to predict optimized treatment in depression

Subject area of study: 
mental health
Title of study: 
International study to predict optimized treatment in depression
Brief outline of the study: 

The purpose of this study is to investigate patient response versus non patient response (i.e “controls” – defined as participants who do not suffer from depression and are not on medication) to antidepressant medications. A combination of brain measures (physical and mental) and body functions will be analysed to determine patient response to antidepressant medications using genetic, psychological and physiological measures. Currently, there are no accurate predictors of how patients will respond to antidepressant treatment with successful treatment.

The three drugs to be used in this study: escitalopram, sertraline and venlafaxine XR and are 3 commonly prescribed drugs for major depression.

Department: 
Monash Alfred Psychiatry Research Centre (MAPrc)
Recruitment start date: 
Fri, 18/09/2009
Recruitment end date: 
Wed, 31/12/2014
Contact person title: 
Dr
Contact person first name: 
Mirjana
Contact person last name: 
Stojkovic
Contact email: 
Contact phone number: 
(03) 9076 6589
Ethics Committee Project Number: 
219/08
Do you have advertising approval?: 
Yes
Approved by: 
Alfred